Sclerodermoid Chronic Graft-versus-host Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-03-17
Clinical Trial Update: Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease [Phase 1, Phase 2]
Clinical trial update for glasdegib in refractory sclerodermoid chronic graft-versus-host disease (CGVHD) across Phase 1 and Phase 2 environ…